Literature DB >> 32787799

Response to correspondence from Koerner and colleagues concerning our paper entitled: The effect of diluting povidone-iodine on bacterial growth associated with speech.

Sivashanth Gnanasekaran1, Sophie Rogers2, Sanj Wickremasinghe2, Sukhpal S Sandhu2.   

Abstract

Clinicians adopt varying strategies for antisepsis with PI, which to this day remains efficient, economical and effective. Clinicians should prudently consider effective PI application, and we thank Koerner and Grzybowski for encouraging debate and raising the profile of this issue.

Entities:  

Keywords:  Anti-VEGF; Endophthalmitis; Intravitreal injection; Povidone-iodine; Pre-injection antisepsis

Mesh:

Substances:

Year:  2020        PMID: 32787799      PMCID: PMC7425590          DOI: 10.1186/s12886-020-01599-3

Source DB:  PubMed          Journal:  BMC Ophthalmol        ISSN: 1471-2415            Impact factor:   2.209


Main text

We thank Koerner and Grzybowski [1] for their comments regarding the study on the effect of diluting povidone-iodine (PI) on bacterial growth associated with speech [2]. We agree that there are no standardized reliable ways to simulate the ocular surface to analyse this in vitro, and stress that the emphasis of this study design is to add to the evidence base. This study demonstrated the differences in PI dilution and significant bacterial culture growth with bacterial droplet dispersal associated with speech. Whilst there is evidence to suggest lower doses of PI is effective [3], we note that other evidence suggest that these lower doses require several applications [4]. Clinicians adopt varying strategies for antisepsis with PI, which to this day remains efficient, economical and effective [5]. Clinicians should prudently consider effective PI application, and we again thank Koerner and Grzybowski for encouraging debate and raising the profile of this issue.
  5 in total

1.  Povidone-iodine concentration and in vitro killing time of bacterial corneal ulcer isolates.

Authors:  Jagger C Koerner; Mary J George; Elizabeth A Kissam; Michael G Rosco
Journal:  Digit J Ophthalmol       Date:  2018-12-19

2.  Optimizing the antisepsis protocol: Effectiveness of 3 povidone-iodine 1.0% applications versus a single application of povidone-iodine 5.0.

Authors:  Megan R Silas; Richard M Schroeder; Richard B Thomson; William G Myers
Journal:  J Cataract Refract Surg       Date:  2017-03       Impact factor: 3.351

Review 3.  The use of povidone-iodine in ophthalmology.

Authors:  Andrzej Grzybowski; Piotr Kanclerz; William G Myers
Journal:  Curr Opin Ophthalmol       Date:  2018-01       Impact factor: 3.761

4.  The effect of diluting povidone-iodine on bacterial growth associated with speech.

Authors:  Sivashanth Gnanasekaran; Sophie Rogers; Sanj Wickremasinghe; Sukhpal S Sandhu
Journal:  BMC Ophthalmol       Date:  2019-02-26       Impact factor: 2.209

5.  Povidone-iodine pharmacokinetics and study design.

Authors:  Jagger Koerner; Andrzej Grzybowski
Journal:  BMC Ophthalmol       Date:  2020-01-17       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.